Cargando…
Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo
PURPOSE: Florbetapir (AV-45) has been shown to be a reliable tool for assessing in vivo amyloid load in patients with Alzheimer’s disease from the early stages. However, nonspecific white matter binding has been reported in healthy subjects as well as in patients with Alzheimer’s disease. To avoid t...
Autores principales: | Saint-Aubert, L., Nemmi, F., Péran, P., Barbeau, E. J., Payoux, P., Chollet, F., Pariente, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978219/ https://www.ncbi.nlm.nih.gov/pubmed/24435769 http://dx.doi.org/10.1007/s00259-013-2656-8 |
Ejemplares similares
-
Cortical florbetapir-PET amyloid load in prodromal Alzheimer’s disease patients
por: Saint-Aubert, Laure, et al.
Publicado: (2013) -
Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer’s Disease: A PET Study
por: Planton, Mélanie, et al.
Publicado: (2020) -
Using PET with (18)F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
por: Camus, V., et al.
Publicado: (2012) -
Multimodal Magnetic Resonance Imaging in Alzheimer’s Disease Patients at Prodromal Stage
por: Eustache, Pierre, et al.
Publicado: (2016) -
Posterior Cortical Atrophy: Does Complaint Match the Impairment? A Neuropsychological and FDG-PET Study
por: Guerrier, Laura, et al.
Publicado: (2019)